Related Experiment Video
Updated: Feb 8, 2026
11:18
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
16.5K
Pediatric oncology services in Colombia
Amaranto Suarez Mattos1, Jairo Aguilera1, Edgar Augusto Salguero1
1Instituto Nacional de Cancerología, Bogota, Colombia.
Colombia Medica (Cali, Colombia)
|July 10, 2018
Summary
Despite sufficient pediatric cancer services in Colombia, few institutions offer comprehensive care. This highlights a gap in integrated treatment for childhood cancer, impacting survival rates.
Area of Science:
- Pediatric Oncology
- Health Services Research
- Public Health Policy
Background:
- Childhood cancer survival rates vary drastically between high- and low-income countries.
- Colombia, a middle-income nation, enacted legislation for comprehensive childhood cancer care units.
- Seven years post-legislation, no institutions have been officially recognized as such.
Purpose of the Study:
- To characterize the current landscape of pediatric oncological services in Colombia.
- To identify institutions capable of becoming comprehensive childhood cancer care units.
Main Methods:
- A descriptive study utilizing secondary data from the Ministry of Health and Social Protection's Special Register of Health Providers.
- Inclusion criteria focused on institutions with enabled medium/high complexity hospitalization, chemotherapy, specialized consultation, emergency, oncological surgery, and radiotherapy/nuclear medicine services.
Main Results:
- 71 institutions offer hematology-oncology consultation.
- 39 provide chemotherapy and hospitalization services.
- Only 9 institutions possess all necessary services for comprehensive care.
Conclusions:
- Colombia demonstrates an adequate supply of individual pediatric cancer care services.
- A significant gap exists in institutions equipped to provide integrated, comprehensive care for childhood cancer.
Related Concept Videos
01:30Primary Healthcare Services
2.2K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.2K
01:30Preventive Healthcare Services
2.2K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.2K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
317
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
317
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
237
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
305
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305